EcoDrugPlus

Ensembl ID : ML305522a
Gene Symbol: -
External references: -
82 Possible Orthologues:

Ensembl ID : ML305524a
Gene Symbol: -
External references: -
222 Possible Orthologues:

Ensembl ID : ML30556a
Gene Symbol: -
External references: -
481 Possible Orthologues:

Ensembl ID : ML306117a
Gene Symbol: -
External references: -
72 Possible Orthologues:

Ensembl ID : ML306123a
Gene Symbol: -
External references: -
44 Possible Orthologues:

Ensembl ID : ML30697a
Gene Symbol: -
External references: -
461 Possible Orthologues:

Ensembl ID : ML30811a
Gene Symbol: -
External references: -
239 Possible Orthologues:

Ensembl ID : ML310320a
Gene Symbol: -
External references: -
319 Possible Orthologues:

Ensembl ID : ML31164a
Gene Symbol: -
External references: -
215 Possible Orthologues:

Ensembl ID : ML31171a
Gene Symbol: -
External references: -
87 Possible Orthologues:

Ensembl ID : ML31181a
Gene Symbol: -
External references: -
214 Possible Orthologues:

Ensembl ID : ML31187a
Gene Symbol: -
External references: -
246 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).